AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Business & Industry
- Amgen contributes $2 million to groundbreaking program providing cancer patients of all backgrounds access to U.S. clinical trials
- AstraZeneca and Cancer Research UK launch Functional Genomics Centre to accelerate the discovery of new medicines
- FDA grants priority review to Roche's Tecentriq in combination with chemotherapy for the initial treatment of extensive-stage small cell lung cancer
- GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company
- Pfizer reaches a global agreement with AbbVie
Research & Development
- Drug cocktail turns off the juice to cancer cells
- MIT engineers repurpose wasp venom as an antibiotic drug
- Statins overprescribed for primary prevention
- Cannabis-based compound may reduce seizures in children with epilepsy
- New Parkinson's disease drug target revealed through study of fatty acids
- CAR-T cell update: Therapy improves outcomes for patients with B-cell lymphoma
- When good macrophages go bad
Conferences & Events
- 21st Annual Superbugs & Superdrugs Conference
- SMi Group announces the 10th Annual RNA Therapeutics Conference
- Pre-Filled Syringes & Injectable Drug Devices Europe 2018
- Social Media in the Pharmaceutical Industry Conference 2019
- Lyophilization USA Conference 2018
- SMi presents the 13th annual industry leading conference: Cold Chain Distribution
- Orphan Drugs and Rare Diseases Conference 2018
Regulatory Affairs
- FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs
- FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
- FDA approves new treatment for patients with acute myeloid leukemia
- FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot
- FDA highlights record-breaking number of generic drug approvals in October